Nephrology Dialysis Transplantation

Similar documents
February Public Opinion Poll. Personalized Cancer Medicine

German Pharmacies. Figures Data Facts Legal disclosure:

Atlas of cancer incidence and mortality. of the. Association of Population-based Cancer Registries in Germany (GEKID)

CHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand

State of play of Leader/CLLD preliminary analysis

TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA

New Zealand. Dialysis and Transplantation Audit

United States Renal Data System (USRDS) International Data Collection Form

Dialysis and Transplantation Audit

CHAPTER 2. Prevalence of Renal Replacement Therapy for End Stage Kidney Disease

CARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017

CHAPTER 4 METHOD AND LOCATION OF DIALYSIS. Nancy Briggs Kylie Hurst Stephen McDonald Annual Report 35th Edition

Chapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less

Chapter 7: Adequacy of Haemodialysis and Serum Bicarbonate

This data collection was discontinued in 2015 (reference year 2013)

02/27/2018. What is a Physician Home Champion? What skills does a home champion need to have?

Federal Health Reporting

21th Budapest Nephrology School Ágnes Haris, Kálmán Polner

USRDS UNITED STATES RENAL DATA SYSTEM

ANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)

NDT Advance Access published July 4, 2006

Chapter 3: National Renal Review 2002: summary report on adult and paediatric renal services

"Schmallenberg" virus: likely epidemiological scenarios and data collection

CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Stephen McDonald. Matthew Jose. Kylie Hurst INDIGENOUS 12-1

Chapter 2. Prevalence of End Stage Kidney Disease. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

Treatment of End-Stage Organ Failure in Canada

Treated ESRD Incidence Rate for Selected Countries, New Patients/Million Pop. 250 USA (All) USRDS 1996

Palliative care SPOTLIGHT HEALTHCARE. Available services do not (yet) meet patient needs Expansion requires clear regulatory strategy

Trends in Hormone Therapy and Breast Cancer Incidence Results from the German Network of Cancer Registries

USRDS 1997 Annual Data Report International Comparisons of ESRD Therapy. Treated ESRD Incidence Rate for Selected Countries,

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL. on the German Alcohol Monopoly

End stage renal disease (ESRD) is a common and. Incidence of end stage renal disease on renal replacement therapy in Nepal ( ) Audit

Acceptance onto Dialysis Guidelines

Canadian Organ Replacement Register Annual Report. Treatment of End-Stage Organ Failure in Canada, 2000 to 2009

CHAPTER 2. Prevalence of Renal Replacement Therapy for End Stage Kidney Disease

Chapter 5 PAEDIATRIC RENAL REPLACEMENT THERAPY. Lee Ming Lee Lim Yam Ngo Lynster Liaw Susan Pee Wan Jazilah Wan Ismail Yap Yok Chin

Management of End Stage Renal Disease-Bangladesh Perspective

Cardiovascular disease profile

Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2003 to 2012

End Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand

High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in Germany

Health networks for the treatment of stroke

CHAPTER 5. Paediatric Renal Replacement Therapy

Chapter Five Clinical indicators & preventive health

The number of patients waiting on the pancreas transplant list fell by 1% during the year, to 224 at 31 March 2017

Implementation. Guideline for the Introduction of Intervention Standards in the Medical Care of Women

Axel Heinemann Institute for Legal Medicine, Hamburg, Germany

Renal replacement therapy for patients with diabetes mellitus in Hong Kong

CHAPTER 3 DEATHS. Stephen McDonald Leonie Excell Brian Livingston

CHAPTER 2. Dialysis in Malaysia

Renal Service Plan for the Midland Region

New Zealand Nephrology Activity Report 2014

Report Finnish Registry for Kidney Diseases. Number of patients at end of year y y. 5 9 y. 0 4 y

ANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

Chapter 8: ESRD Among Children, Adolescents, and Young Adults

CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Matthew Jose Stephen McDonald Leonie Excell

The number of patients waiting on the pancreas transplant list fell by 7% during the year, to 252 at 31 March 2015

Difference in practical dialysis therapy between East Asia and US/EU

ANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)

An epidemic of renal failure among Australian Aboriginals

Incidence of new patients starting RRT

The Nephrology Society of Thailand has been collect THE STATUS OF, AND OBSTACLES TO, CONTINUOUS AMBULATORY PERITONEAL DIALYSIS IN THAILAND

Is Pancreas Transplantation Getting Old? Single-Center Experience in an Aging Society

Transplant Activity in the UK

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 28 March 2012

Renal Transplant Registry Report 2008

Why has the gross mortality of dialysis patients increased in Japan?

2017 USRDS ANNUAL DATA REPORT KIDNEY DISEASE IN THE UNITED STATES S611

PATIENT SELECTION FOR DECEASED DONOR KIDNEY ONLY TRANSPLANTATION

It is important upfront to realize and believe that, like many adults,

Starting with Home Dialysis. Budapest Nephrology School 2016 Ágnes Haris MD, PhD, Kálmán Polner MD St. Margit Hospital, Budapest

ANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)

AJNT. Special Article. Renal Replacement Therapy in Sudan, Sarra Elamin 1*, Wafaa Obeid 2, Hasan Abu-Aisha 1. Abstract

National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC)

Chapter 7: ESRD among Children, Adolescents, and Young Adults

morbidity & mortality

Jadranka Buturović-Ponikvar Department of Nephrology, University Medical Center, Ljubljana, Slovenia

What Happened? 3/20/2017. Changing Lives and Making a Difference: Home Hemodialysis Stories. Brigitte Schiller, MD, FACP, FASN

Summary HTA. Arthroplasty register for Germany. HTA-Report Summary. Gorenoi V, Schönermark MP, Hagen A

CKD Prevention Program Protocol

Deceased donation data in the UK. Paul Murphy National Clinical Lead for Organ Donation United Kingdom

Geriatric Nephrology. Murtener Tage

National Surveillance System for Dialysis Centre and Dialysis Associated Diseases

CHAPTER 5. Haemodialysis. Kevan Polkinghorne Hannah Dent Aarti Gulyani Kylie Hurst Stephen McDonald

New Zealand Kidney Allocation Scheme

Epidemiology of kidney diseases in children

Estimating vaccination coverage in the absence of immunisation registers the German experience

Chapter 6: Transplantation

Kidney Transplantation in the Elderly. Kristian Heldal, MD, PhD Telemark Hospital Trust, Skien, Norway and University of Oslo

World Congress of Nephrology, Mexico City

Improving Survey Methods

RRT and conservative management

ORIGINAL ARTICLE. 2 and Doris Gabel. Summary

SERVICE SPECIFICATION 6 Conservative Management & End of Life Care

Chapter XII. ESRD-International comparisons. of ESRD Therapy. USRDS 1999 Annual Data Report International Comparisons of ESRD Therapy.

Options in Renal Replacement Therapy: When, whom, which? Prof Dr. Serhan Tuğlular Marmara University Medical School Division of Nephrology

Secular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009

Transcription:

Nephrol Dial Transplant (1999) 14: 1085 1090 Dialysis and Transplantation News Nephrology Dialysis Transplantation Annual Report of the German Renal Registry 1998 Ulrich Frei1, Hans-Jürgen Schober-Halstenberg2 and the QuaSi-Niere Task Group for Quality Assurance in Renal Replacement Therapy Members of the Task Group: K. Albrecht, H. Becker, W. J. Brech, K. Erben, W. Fassbinder, U. Frei (Chair), K.-H. Götz, R. Hoffmann, M. Jeschke, H. Kütemeyer, A. Landmann, C. Müller, G. Offner, B. Peschke, H. T. Riegel, Ch. Szymkowiak, Ch. Tast and K. Thieler 1Department of Nephrology and Medical Intensive Care, Universitätsklinikum Charité, Campus Virchow-Klinikum and 2Projektgeschäftsstelle QuaSi-Niere, Berlin, Germany Abstract During the past 3 years, the basis of a therapy ( RRT) in Germany as reported previously German Renal Registry has been established. An agreement [1]. QuaSi-Niere collects annually in its centre survey between end-stage renal disease ( ESRD) therapy data on the incidence, prevalence, treatment modality, providers, insurance companies and the government morbidity and mortality of end-stage renal disease has been reached to fund and support the registry ( ESRD). Individual patient data are collected continuously office and its electronic data base. An overall acceptable throughout the year. The office of the registry is compliance has been achieved to provide data volun- based at the Berlin Medical Association and is funded tarily, although in the future the data submission will by a grant of the Federal Ministry of Health and gets have to be mandatory to achieve complete data sam- financial support from the German dialysis providers pling within an acceptable time frame. In Germany, ( Kuratorium für Dialyse und Nierentransplantation 713 patients per million population (p.m.p.) are on e.v. KfH, Patientenheimversorgung Gemeinnützige renal replacement therapy ( RRT). The incidence of Stiftung PHV, Deutsche Dialysegesellschaft niedergel- new patients commencing RRT is 156 p.m.p. These assener Ärzte e.v. DDnÄ) and the patients association numbers are comparable with those reported from ( Dialysepatienten Deutschlands e.v.) as well. In the other European countries such as France, Italy and future, QuaSi-Niere will be financed by the German Spain, but significantly lower than those reported from health insurances and the dialysis providers. the US or Japan. More than 92% of all dialysis patients QuaSi-Niere gathers its information by voluntary are treated by haemodialysis and only a limited number reporting of almost all of the German RRT facilities. with peritoneal dialysis. Approximately 25% of the An on-line reporting system for continuous data assessment patients have a functioning kidney graft. The transplantation on morbidity and outcome parameters is under rate of 25 p.m.p. is far from sufficient if development. This will avoid the actual burden of most compared with Spain, Austria or the US. Although an of the paper work with individual patient registration increasing number of diabetic patients commenced and follow up. RRT, the percentage, i.e. ~30%, is less than in the The individual patient register basically is supported US or Japan. The annual growth of the population on by the trust and confidence of all those patients in renal replacement cannot currently be given precisely Germany, who gave their informed consent to deliver because the database is still limited, but it seems to be their personal data. Major efforts have been successful ~3 4%. in establishing an effective system of data protection which has been approved by the federal and state data protection board. Background Compared with 1995, the centre survey 1996 has been modified and the questions have been rephrased This is the third Report of the German Renal Registrythe completely voluntary basis of reporting which to make them more precise. A continuous concern is Project Quality Assurance in Renal Replacement Therapy (QuaSi-Niere) since its founding in 1994, and necessitates intensive efforts to obtain a nearly comthe first one published in English. QuaSi-Niere has plete data set. Although a legal basis for quality begun to establish a new database for renal replacement assurance in the medical supply exists, there is no formal obligation for the institutions to provide data. A mandatory reporting seems to be necessary and Correspondence and offprint requests to: U. Frei, Department of Nephrology, Virchow-Klinikum, Augustenburger Platz 1, D-13353 hopefully will be established in the future. Berlin, Germany. The data provided have been analysed concerning 1999 European Renal Association European Dialysis and Transplant Association

1086 completeness and plausibility, and cross-checked with other available sources. Comparison with regional, national and international registries has been made. The present report is divided into two parts, i.e. the centre survey and patient survey. QuaSi-Niere has made this Annual Report available on its website (http://www.quasi-niere.org) in the Internet. U. Frei et al. 60% CAPD. Thirty of all centres carried out transplant patient follow-up themselves, whereas 80% did this in cooperation with a special transplant centre. Twentynine centres reported taking care of pediatric patients, defined as care of ESRD children and adolescents (children <15 years of age, or adolescents 18 years of age). Centre survey 1996 Prevalence of adult ESRD patients (>18 years of age) At the end of 1996, the number of all patients on Known centres and reporting frequency according to ESRD therapy (dialysis or transplant) was 57 803, or federal state 713 p.m.p. Of these, 42 952 were treated with dialy- sis and 14 851 had a functioning transplant, 39 812 At the end of 1996 ( 31.12.96), 858 different centres were treated with one modality of haemodialysis providing RRT therapy were known to the registry (HD/HF/HDF) and 3140 with peritoneal dialysis, i.e. office. Of these, 809 or 94.8% replied to the centre only 7.3% of the dialysis population receives peritoneal survey. The reporting frequency was different in the dialysis. A total of 35 252 patients were treated with German federal states, with frequencies between 80 HD, 3953 with HDF and 577 with HF. Home HD and 100%, the lowest in Hamburg and the highest in played only a minor role: 643 out of 39 812 HD Lower Saxony, Saarland and Thuringia. Up to July patients performed home dialysis. On average, 492 1998, 85 additional facilities for RRT have been p.m.p. were treated by HD and 524 with any mode of registered. dialysis. Again significant regional differences were found (see Table 3). The prevalence of dialysis patients Characteristics of facilities in ESRD therapy varied between 427 p.m.p. in Saxony and 647 p.m.p. in Bavaria. A total of 14 851 patients were reported to This item addressed the number of available stations live with a functioning transplant, i.e. 26% of the for haemodialysis ( HD), haemofiltration ( HF ) or ESRD population. This figure should be treated with haemodiafiltration ( HDF), the availability for periton- caution, however, because there may have been some eal dialysis training and care and the cooperation with overreporting, the same patient being reported by the transplant centres as well as transplant follow-up. On primary nephrologist and as well as by the transplant average, 176 HD/HF/HDF stations p.m.p. have been centres. available. On average, 2.8 patients are treated per station (range 1.8 3.7, see Table 2). Notable differences Incidence of new adult ESRD patients were found between federal states, ranging from 115 p.m.p. in Saxony to 198 p.m.p. in Baden-Württemberg During 1996, 12 265 new adult patients commenced (see Table 2). Thirty-four of the centres offered ESRD therapy. This is an incidence of 156 new patients in-centre APD/IPD, 45% APD/CCPD at home and p.m.p. Peritoneal dialysis as the first treatment modal- ity was reported in 7.7%. The incidence varied between 123 p.m.p. in Mecklenburg-Western and 206 p.m.p. in Saarland (see Table 4). Table 1. Summary overview on ESRD therapy in Germany 1996 (compared with 1995) Viral infections 1996 (1995) The number of ESRD patients suffering from viral infections [hepatitis B virus ( HBV ), hepatitis C virus Total no. of ESRD patients 57 803 (54 656) ( HCV ) and human immunodeficiency virus ( HIV )] Children <15 years 568 (267) was assessed. A total of 780 dialysis patients (1.8%) Adolescents 15 18 years 293 (137) were infected by HBV, 2365 ( 5.5%) had HCV antibod- Prevalence of ESRD therapy 713 per million (674) ies and 24 HIV antibodies. Out of the transplanted Total no. of dialysis patients 42 952 (41 350) patients, 484 were infected by HBV (3.25%), 847 ( 5.7%) had HCV antibodies and seven had HIV Prevalence 524 per million (511) Patients on haemodialysis 39 812 (38 268) antibodies. Patients on peritoneal dialysis 3140 (3082) Patients with a functioning transplant 14 851 (13 306) Transplantation Commencement of ESRD therapy 12 406 (11 731) As mentioned above, the transplant figures may be Incidence 156 per million (145) inflated by overreporting. Nevertheless, it is useful to Haemodialysis treatment 11 302 (10 568) Peritoneal dialysis treatment 963 (1163) compare the states with respect to overall transplant Children and adolescents 141 (124) activity and new registrations for the waiting lists Deceased dialysis patients 7119 (6392) ( Table 5). Where available, data of Eurotransplant are included. A total of 10 827 patients was reported to be

Annual Report of the German Renal Registry 1998 1087 Table 2. Number of dialysis stations and patients per station according to federal state Patients Stations for Patients per Stations HD/HF/HDF station p.m.p. Baden-Württemberg 4761 2011 2.36 198 Bavaria 7063 2022 3.49 172 Berlin 1733 634 2.73 183 Brandenburg 1030 351 2.93 138 Bremen 446 202 2.21 225 Hamburg 943 387 2.44 229 Hesse 3514 1094 3.21 185 Mecklenburg-Western 837 334 2.51 179 Lower Saxony 3418 1471 2.32 194 North Rhine-Westphalia 8226 054 2.69 173 Rhineland-Palatine 2042 643 3.18 166 Saarland 515 202 2.55 186 Saxony 1902 536 3.55 115 Saxony-Anhalt 1202 370 3.25 132 Schleswig-Holstein 917 487 1.88 182 Thuringia 1263 470 2.69 185 Table 3. Prevalence of patients according to treatment modality according to federal state Patients Patients Prevalence Prevalence HD/HDF/HD CAPD/CCPD/IPD HD/HDF/HF dialysis p.m.p. p.m.p. Baden-Württemberg 4761 493 469 518 Bavaria 7063 548 600 647 Berlin 1733 166 500 548 Brandenburg 1030 67 405 431 Bremen 446 29 650 693 Hamburg 943 54 558 590 Hesse 3514 308 593 645 Mecklenburg-Western 837 28 449 464 Lower Saxony 3418 302 451 491 North Rhine-Westphalia 8226 668 465 503 Rhineland-Palatinate 2042 153 526 566 Saarland 515 62 475 532 Saxony 1902 78 410 427 Saxony-Anhalt 1202 100 430 465 Schleswig-Holstein 917 44 342 359 Thuringia 1263 40 496 512 Total 39 812 3140 registered on the waiting list. This may include active and non-active (temporarily not transplantable) patients ( Eurotransplant: active waiting list: 8051 for kidney and 51 for kidney + pancreas). The reported number of transplants performed, i.e. 2429, again exceeds the Eurotransplant figure of 2016 (1784 cadaver kidneys, 103 kidney + pancreas and 129 live donor kidneys). The proportion of patients registered on the waiting list in relation to the number of patients who commenced dialysis differed markedly between states, i.e. 11.6% in Thuringia and 40.8% in Saarland. Return to dialysis after graft failure In 1996, 857 patients (822 adults, 31 children and four adolescents) were reported to have had graft failure. This complication markedly reduces the net increase in the number of transplanted patients. Incidence and prevalence of children and adolescents on ESRD therapy At the end of 1996, 861 children and adolescents were reported, 568 aged <15 and 293 aged 15 18 years, yielding a prevalence of 11 p.m.p. A total of 141 children or adolescents (1.7 p.m.p.) commenced ESRD therapy in 1996, 90 children and 51 adolescents. The treatment modality was HD in 167 cases (82 children and 85 adolescents), peritoneal dialysis in 180 cases (141 children and 39 adolescents) and a kidney transplant in 514 cases ( 345 children and 169 adolescents). A total of 155 patients (116 children and 39 adoles-

1088 Table 4. Patients commencing ESRD (incidence) according to federal state U. Frei et al. Patients Start with Start with Children/ Incidence HD PD adolescents p.m.p. commencing RRT Baden-Württemberg 1440 1283 135 22 141.9 Bavaria 2091 1902 160 29 177.7 Berlin 611 537 63 11 176.3 Brandenburg 435 411 22 2 171.1 Bremen 124 118 6 0 180.8 Hamburg 267 241 19 7 158.1 Hesse 926 833 83 10 156.4 Mecklenburg-Western 230 221 8 1 123.3 Lower Saxony 951 854 89 8 125.5 North Rhine-Westphalia 2493 2273 196 24 141.0 Rhineland-Palatinate 636 579 57 0 163.9 Saarland 223 189 25 9 205.7 Saxony 632 590 31 11 136.2 Saxony-Anhalt 491 453 34 4 175.5 Schleswig-Holstein 432 417 15 0 161.2 Thuringia 424 401 20 3 166.5 Total 12 406 11 302 963 141 Table 5. Transplantationa Patients on Transplanted New % Dialysis % Dialysis % incident on waiting list patients registered patients on patients waiting listb patients waiting list transplanted Baden-Württemberg 1089 259 295 20.7 4.9 20.5 Bavaria 1677 424 489 22.0 5.6 23.4 Berlin 663 136 181 34.9 7.2 29.6 Brandenburg 269 52 78 24.5 4.7 17.9 Bremen 177 55 36 37.3 11.6 29.0 Hamburg 252 72 59 25.3 7.2 22.1 Hesse 986 179 274 25.8 4.7 29.6 Mecklenburg-Western 127 44 56 14.7 5.1 24.3 Lower Saxony 1135 226 282 30.5 6.1 29.7 North Rhine-Westphalia 2888 601 837 32.5 6.8 33.6 Rhineland-Palatinate 299 61 100 13.6 2.8 15.7 Saarland 91 21 91 15.8 3.6 40.8 Saxony 379 85 146 19.1 4.3 23.1 Saxony-Anhalt 209 40 89 16.1 3.1 18.1 Schleswig-Holstein 311 125 200 32.4 13.0 46.3 Thuringia 275 49 75 21.1 3.8 11.6 Total 10 827 2429 3288 aactive waiting list Eurotransplant (1996): 8051 patients (kidney) and 61 patients (kidney+pancreas). Kidney transplantations: 1784, kidney+pancreas 103; living kidney donors: 129 (Eurotransplant Annual Report, 1996). bpercentage of incident patients as a proportion of all patients on the waiting list for transplantation. cents) received a transplant in 1996. Twelve children died in this year. Number of deceased adult dialysis patients A total of 7119 dialysis patients were reported to have died in 1996. The total number of transplanted patients who died in 1996 is not available. Demography of ESRD therapy in Germany The number of patients treated by any method of dialysis increased between 1995 and 1996 by 1602 patients although the 1995 database is not completely comparable. This represents an increase of 3.8%. When one calculates the net increase, i.e. the inflow of dialysis patients (new patients and returns from transplantation) minus the outflow (deceased and transplanted

Annual Report of the German Renal Registry 1998 1089 Fig. 1. Population pyramid of all patients on RRT. Fig. 3. Age distribution of patients on haemodialysis. Fig. 2. Population pyramid Germany (1995). Fig. 4. Age distribution of patients on peritoneal dialysis. patients), there remained an unexplained gap of >2000 identification data set. The age distribution of all cases. Therefore, calculations concerning the future registered patients is given in Figure 1. For comparison, development of the dialysis population relying on the the age distribution of the German general population actual database are not feasible. is added in Figure 2. Out of the registered patients ( 42 353), 18 727 (42%) were female compared with Patient survey 51% in the general population. This data set together with the German population census might give a suitable basis to calculate further population growth Between August 1996 and April 1998, 42 535 individual provided there is no significant change with time patients were registered in our patient database concerning the proportion of patients commencing through the data trustee s office. This restricted initial dialysis with respect to primary disease and with respect registration contained date of birth, gender, primary to life expectancy. renal disease (coded according to the EDTA/ERA The distribution according to age and gender is code system), date of first ESRD treatment and current given for the different current treatment modalities, treatment modality. i.e. HD ( Figure 3), peritoneal dialysis ( Figure 4) and The following analysis is based on the limited patient transplant patients ( Figure 5). The information on the

1090 U. Frei et al. Fig. 5. Age distribution of transplanted patients. Fig. 7. Distribution of primary renal diseases in the incident population 1997. commenced ESRD therapy in 1997 (incidence population, Figure 7) was taken from this data set. It is interesting to note the percentage of 31% diabetics commencing ESRD therapy in 1997 compared with 21% in the prevalent population, pointing to their shorter life expectancy. The reverse is true for patients with glomerulonephritis, only 16% in the incidence population but 25% in the prevalence population. References Fig. 6. Distribution of primary renal diseases in the prevalent population. distribution of primary diseases in the prevalent population (Figure 6) as well in all patients who have 1. Frei U. Quality assurance in renal replacement therapy (RRT ) background of a developing German National Registry for RRT. QuaSi-Niere Task Group. Nephrol Dial Transplant 1995; 10: 442 443 2. US Renal Data System, USRDS 1998 Annual Data Report, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, April 1998. Available in paper and microfiche versions from National Technical Information Service (NTIS), Springfield, VA 3. US Renal Data System, USRDS 1997 Annual Data Report, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, April 1997. Available in paper and microfiche versions from National Technical Information Service (NTIS), Springfield, VA. (Published without reference tables or appendices in Am J Kidney Dis, 1997; 30 [Suppl 1]: S1 S213)